Off-label prescribing for children with chronic diseases in Nigeria; findings and implications
Kazeem Adeola Oshikoya1, Ibrahim Adekunle Oreagba2, Brian Godman3,4,5
1a Pharmacology Department , Lagos State University College of Medicine , Lagos , Nigeria.
Insights
Off-label prescribing for pediatric epilepsy, asthma, and sickle cell anemia in Nigeria was studied. The overall rate of off-label prescriptions was found to be low, primarily related to dosage adjustments.
Area of Science:
- Pediatric Pharmacology
- Drug Utilization Studies
- Global Health
Background:
- Off-label medication use in children with chronic conditions is under-documented, particularly in developing nations.
- This study addresses the need for data on pediatric prescribing practices in Nigeria.
Purpose of the Study:
- To investigate the prevalence and patterns of off-label prescribing in Nigerian children with epilepsy, asthma, and sickle cell anemia.
Main Methods:
- Retrospective review of prescriptions for children aged 16 years and younger.
- Data collected from pediatric clinics in Lagos, Nigeria, between January and October 2015.
- Utilized British National Formulary for children and American Hospital Formulary Service Drug information as references.
Main Results:
- Out of 1746 prescriptions for 477 patients, 7.7% were off-label, predominantly due to dosage (68.9%).
- Nervous system and anti-infective agents were most prescribed; off-label use was 9.5% and 8.2% respectively.
- Children with epilepsy accounted for the majority of off-label prescriptions (69.6%).
Conclusions:
- Off-label prescribing does occur in Nigerian children with epilepsy, asthma, and sickle cell anemia.
- The overall rate of off-label prescribing in this population appears to be low.
Background:
Prescribing medicines in an off-label manner for children with chronic conditions is sparsely documented, even more so among developing countries. This needs addressing. The objective of this research was to investigate the extent of off-label prescribing among children with epilepsy, asthma, and sickle cell anaemia in Nigeria.
Methods:
Prescriptions for children ≤16 years documented in their case files that attended paediatric clinics in Lagos, Nigeria, for these three conditions between January and October 2015, were reviewed retrospectively to extract data on the medicines prescribed. British National Formulary for children and American Hospital Formulary Service Drug information were used as references.
Results:
477 patients received 1746 prescriptions. Off-label prescriptions were seen in 7.7% of prescriptions, related to dose (93; 68.9%), indication (22; 16.3%), and age (20; 14.8%). Nervous system (525; 30.1%) and anti-infective (441; 25.2%) medicines were the most prescribed but only 9.5% and 8.2% of the respective prescriptions were off-label. Children with epilepsy received the most number (94; 69.6%) of off-label prescriptions. The three chronic conditions did not associate significantly with the category of off-label medicine prescribed (p = 0.925).
Conclusion:
Off-label prescribing for children with epilepsy, asthma and sickle cell anaemia occurs. Encouragingly, the overall rate appears low in Nigeria.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Factors Affecting Drug Response: Overview


